Quote on Sun pharma by Mr. Yash Gupta, Angel Broking Ltd
Below is quote on Sun pharma by Mr. Yash Gupta, Equity Research Associate, Angel Broking Ltd
Sun Pharmaceuticals reported a good set of numbers for Q1FY2022, posting revenue growth of 30% at ₹9669.4 crores in Q1FY2022 which is above the market expectations. The domestic market has done well for the company in this quarter up by 38.5%. We have seen strong growth reported by all the pharma companies on the back of a recovery in the acute therapeutic segment. We expect domestic growth momentum to continue in this financial year. US formulation market reported growth of 30% which is above the market expectations. The overall company reported one of the best quarterly results in a very long time. We have a positive outlook on Sun Pharmaceuticals Ltd.
Above views are of the author and not of the website kindly read disclaimer
Tag News
On the higher side, immediate resistance is seen around 36000 - 36200 levels - Angel One